Madhav Madurantakam Royam, M.Sc, M.Tech
University of Warwick; Puxty LabI am Madhav Madurantakam Royam, a first year Ph.D. student at Puxty’s Lab at the School of Life Sciences, University of Warwick, UK. My Ph.D. work focuses on elucidating the role of tRNA’s in mycobacteriophages with respect to its virulence and host range. My work involves evolution of mycobacteriophages against their hosts and generating tRNA mutants in them. I have finished my Master of Science (MSc) and Master of Technology [By Research] degrees from Vellore Institute of Technology, Vellore, India. I have had experiences on working with Gram-negative pathogens such as Citrobacter sp. Pseudomonas aeruginosa, Klebsiella sp, and Escherichiacoli. During my Master of Technology [By Research] degree, I have isolated lytic bacteriophages against Citrobacter sp. and characterized their in vitro & in vivo efficacy in a zebrafish model.
My research interests are to understand the evolution of phages against their hosts and characterise their defence mechanism them using various molecular biology and bioinformatic tools.
Loading issues…
- Looking back on Phage Futures Europe 2022 — Part 2Phage Futures Europe was recently held in Amsterdam, where the phage biotech field came together to discuss recent progress in clinical phage therapy and commercialization. Jessica Neubauer and Madhav Madurantakam Royam are back this week…
- Looking back on Phage Futures Europe 2022 — Part 1Last month Madhav Madurantakam Royam and Jessica Neubauer attended Phage Futures Europe in Amsterdam, and they've brought us a sneak-peek into what they learned!
- Intralytix: then and nowThis week Madhav Madurantakam Royam, a PhD student at the University of Warwick, talks to Dr. Alexander Sulakvelidze, founder and CEO of Intralytix, one of the first modern phage companies to have products on the market.
- Phage therapy at the Queen Astrid Military Hospital: a conversation with Jean-Paul PirnayThis week, Madhav Madurantakam Royam, a PhD student at the University of Warwick, talks to Dr. Jean-Paul Pirnay about how the Queen Astrid Military Hospital in Belgium is advancing phage therapy.
- A novel phage with unusual pyrimidine nucleotide substitution: Q&A with Dr. Branko Rihtman and Dr. Richard PuxtyThis week, Madhav Madurantakam Royam interviewed Dr. Branko Rihtman and Dr. Richard Puxty about their new paper describing an unusual nucleotide substitution from deoxythymidine to deoxyuridine in a novel family of phages belonging to…
- How to analyze your phage genomes, and stories from a multi-decade phage career: triple webinar recap issue!This week, we (co-)hosted three webinars: Africa Phage Forum #2 with Dr. Evelien Adriaenssens, the first event of a new IBRC Phage Bioinformatics Series with Deborah Jacobs-Sera, and PHAVES #12 with Dr. Betty Kutter. Here are the…
